Company: PHAT
Filing Date: 2025-04-23
Form Type: DEF 14A
Source: 0000950170-25-057326
Chunk: 31

Company: Phathom Pharmaceuticals, Inc.
Filing Date: 2025-04-23
Form: DEF 14A
Chunk 31
---
 as by exercising stock options). Whether, and to what extent, a non-employee director realizes a financial benefit from the awards will depend on our actual operating performance, stock price fluctuations and the non-employee director’s continued service on our board. (2) The amounts shown in this column represent the grant-date fair value of RSUs granted in 2024 calculated in accordance with ASC 718. See Note 7 to our financial statements included in our 2024 Form 10-K for a discussion of the relevant assumptions used in determining the grant date fair value pursuant to ASC 718. These amounts do not reflect whether the recipient has actually realized or will realize a financial benefit from the awards (such as by exercising stock options). Whether, and to what extent, a non-employee director realizes a financial benefit from the awards will depend on our actual operating performance, stock price fluctuations and the non-employee director's continued service on our board. Each non-employee director received an annual grant of 10,500 RSUs on May 23, 2024, with a grant date fair value of $10.30 per share, which was the closing price of our stock on the date of grant. (3) Dr. Topper is one of the partners at Frazier. The cash retainers payable to Dr. Topper were paid to Frazier Life Sciences. The aggregate number of shares underlying stock options and RSUs at December 31, 2024 for the individuals who served as non-employee directors during 2024 was as follows:

|                           | Name |     |          Number of 
         Securities 
 Underlying Options 
     Outstanding at 
  December 31, 2024 |     |     |         Number of 
        Securities 
        Underlying 
  Restricted Stock 
             Units 
    Outstanding at 
 December 31, 2024 |
|:--------------------------|:-----|:----|-------------------:|:----|:----|------------------:|
| Michael F. Cola           |      |     |            113,360 |     |     |            10,500 |
| Frank Karbe               |      |     |             62,500 |     |     |            10,500 |
| Heidi Kunz                |      |     |            113,360 |     |     |            10,500 |
| Asit Parikh, M.D., Ph.D.  |      |     |             45,000 |     |     |